The significance of the visible tumor on preoperative magnetic resonance imaging in localized prostate cancer

Bray, 2013, Global estimates of cancer prevalence for 27 sites in the adult population in 2008, Int J Cancer, 132, 1133, 10.1002/ijc.27711 Chung, 2019, The incidence, mortality, and risk factors of prostate cancer in Asian men, Prostate Int, 7, 1, 10.1016/j.prnil.2018.11.001 Stamey, 1993, Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer, Cancer, 71, 933, 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L Secin, 2007, Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer, Eur Urol, 51, 764, 10.1016/j.eururo.2006.10.058 McClure, 2012, Use of MR imaging to determine preservation of the neurovascular bundles at robotic-assisted laparoscopic prostatectomy, Radiology, 262, 874, 10.1148/radiol.11103504 Grossfeld, 2001, Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database, J Urol, 165, 851 Ward, 2005, Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent ofprostate-specific antigen testing: 15-year outcome, BJU Int, 95, 751, 10.1111/j.1464-410X.2005.05394.x Mottet, 2017, EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and LocalTreatment with Curative Intent, Eur Urol, 71, 618, 10.1016/j.eururo.2016.08.003 Yoshimitsu, 2008, Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology, J Magn Reason Imaging, 27, 132, 10.1002/jmri.21181 Woodfield, 2010, Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy, Am J Roentgenol, 194, W316, 10.2214/AJR.09.2651 Shigemura, 2013, Can diffusion-weighted magnetic resonance imaging predict a high Gleason score of prostate cancer?, Korean J Urol, 54, 234, 10.4111/kju.2013.54.4.234 Cheng, 2003, Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA <or=10, and clinically localized prostate cancer, Int J Radiat Oncol Biol Phys, 55, 64, 10.1016/S0360-3016(02)03820-8 Nishida, 2011, Incremental value of T2-weighted and diffusion-weighted MRI for prediction of biochemical recurrence after radical prostatectomy in clinically localized prostate cancer, Acta Radiol, 52, 120, 10.1258/ar.2010.100293 Weinreb, 2016, PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2, Eur Urol, 69, 16, 10.1016/j.eururo.2015.08.052 Siddiqui, 2013, Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy, Eur Urol, 64, 713, 10.1016/j.eururo.2013.05.059 Somford, 2013, The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer, J Urol, 190, 1728 Stamatakis, 2013, Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer, Cancer, 119, 3359, 10.1002/cncr.28216 Chamie, 2014, The role of magnetic resonance imaging in delineating clinically significant prostate cancer, Urology, 83, 369, 10.1016/j.urology.2013.09.045 Sonn, 2014, Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen, Eur Urol, 65, 809, 10.1016/j.eururo.2013.03.025 Langer, 2008, Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers, Radiology, 249, 900, 10.1148/radiol.2493080236 Hambrock, 2011, Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer, Radiology, 259, 453, 10.1148/radiol.11091409 Oto, 2011, Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis, Am J Roentgenol, 197, 1382, 10.2214/AJR.11.6861 Rais-Bahrami, 2013, Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer, J Urol, 190, 1721 Le, 2015, Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology, Eur Urol, 67, 569, 10.1016/j.eururo.2014.08.079 Cheng, 1999, Correlation of margin status and extraprostatic extension with progression of prostate carcinoma, Cancer, 86, 1775, 10.1002/(SICI)1097-0142(19991101)86:9<1775::AID-CNCR20>3.0.CO;2-L Park, 2011, Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results, Eur Radiol, 21, 1111, 10.1007/s00330-010-1999-9 Park, 2014, Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy, Am J Roentgenol, 202, W459, 10.2214/AJR.13.11381 Cabrera, 2008, Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging afavorable prognostic finding in patients who select active surveillance?, Radiology, 247, 444, 10.1148/radiol.2472070770 Lee, 2013, Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol, Jpn J Clin Oncol, 43, 553, 10.1093/jjco/hyt041 D'Amico, 1998, Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, J Am Med Assoc, 280, 969, 10.1001/jama.280.11.969